Stay updated on NRP104 Safety & Efficacy in Adult ADHD Clinical Trial
Sign up to get notified when there's something new on the NRP104 Safety & Efficacy in Adult ADHD Clinical Trial page.

Latest updates to the NRP104 Safety & Efficacy in Adult ADHD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has removed detailed information about a Phase III clinical study of NRP104 for ADHD, including the study's purpose, methodology, and inclusion/exclusion criteria, while adding a new revision number.SummaryDifference38%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe web page has added several new topics related to psychomotor disorders and behavioral symptoms, including specific areas such as neurobehavioral manifestations and aberrant motor behavior in dementia.SummaryDifference0.4%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to NRP104 Safety & Efficacy in Adult ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NRP104 Safety & Efficacy in Adult ADHD Clinical Trial page.